Latanoprost Stada

Latanoprost, the active ingredient in Latanoprost Stada, is a prostaglandin F2α analog presented as an eye drops solution for ocular (topical) use. It treats primary open-angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma‑related conditions.

Primary open-angle glaucoma: reduces intra‑ocular pressure and slows disease progression. Ocular hypertension: lowers intra‑ocular pressure to prevent conversion to glaucoma. Secondary open-angle glaucoma: helps control pressure when other causes are present.

Latanoprost may cause several ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of the iris. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea affecting vision. - Macular edema: fluid accumulation in the central retina. - Paradoxical intra‑ocular pressure rise: unexpected pressure increase. - Endophthalmitis: intra‑ocular infection requiring urgent care.

Before using Latanoprost, consider the following safety measures.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: unknown excretion; use with caution. Contraindications: active ocular infection or inflammation. Contact lens wearers: may cause deposits; remove lenses before instillation. Monitoring: intra‑ocular pressure should be assessed regularly. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analogs may cause excessive pressure lowering. - Topical non‑steroidal anti‑inflammatory drugs can reduce Latanoprost efficacy. - Systemic prostaglandin analogs may increase risk of systemic side effects.

Moderate Interactions (Monitor Closely):\n- Beta‑blocker eye drops: monitor for additive pressure reduction. - Carbonic anhydrase inhibitor eye drops: watch for cumulative intra‑ocular pressure effect.